Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-06-09 10:03 am |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Gopinathan Suma SVP, Discovery |
0 | $0 | 637,980 (Direct) |
View |
Ownership |
2025-06-06 5:40 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Martens Rachel Yap VP, Partnerships & Corp Strat |
0 | $0 | 553,346 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:25 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:24 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:23 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:22 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | Cheung Ivan Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:22 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:21 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-06-03 Option Award |
2025-06-03 4:20 pm |
N/A 2035-06-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
193,118 | $0 | 193,118 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-13 5:52 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
36,810 | $0 | 85,174 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-13 5:51 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director |
36,810 | $0 | 36,810 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-13 5:50 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
36,810 | $0 | 203,865 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-13 5:50 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
36,810 | $0 | 124,459 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-13 5:49 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
36,810 | $0 | 285,174 (Direct) |
View |
| 2025-05-13 Exercise |
2025-05-13 5:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
36,810 | $0 | 45,755,796 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-03 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
17,862 | $0.67 | 132,068 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
46,430 | $0 | 132,068 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-03 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources |
30,004 | $0.67 | 253,976 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources |
98,956 | $0 | 253,976 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-03 4:32 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
43,434 | $0.67 | 508,494 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:32 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
126,814 | $0 | 508,494 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-03 4:31 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer |
65,308 | $0.67 | 304,495 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:31 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer |
137,934 | $0 | 304,495 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-03 4:30 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm |
9,096 | $0.67 | 64,924 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:30 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm |
24,673 | $0 | 64,924 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-03 4:28 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. |
45,622 | $0.67 | 433,045 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:28 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. |
128,940 | $0 | 433,045 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:22 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
371,080 | $0 | 371,080 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:22 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources |
1,082,960 | $0 | 1,082,960 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:21 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
1,255,150 | $0 | 1,255,150 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:20 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer |
1,516,950 | $0 | 1,516,950 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:20 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Comm |
961,420 | $0 | 961,420 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:19 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. |
1,276,220 | $0 | 1,276,220 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:18 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Corrigan Brian SVP, Regulatory & QA |
1,121,660 | $0 | 1,121,660 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:17 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer |
1,201,780 | $0 | 1,201,780 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:16 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Exton Michael Chief Executive Officer |
3,774,480 | $0 | 3,774,480 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-02 4:09 pm |
N/A 2035-01-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer |
230,000 | $0 | 230,000 (Direct) |
View |
Ownership |
2025-01-02 4:06 pm |
N/A 2035-01-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer |
0 | $0 | 230,000 (Direct) |
View |
Ownership |
2024-12-16 7:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Artal Participations S.a r.l. Director 10% Owner |
0 | $0 | 136,180,481 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-02 5:41 pm |
N/A 2034-12-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Cheung Ivan Director |
186,685 | $0 | 186,685 (Direct) |
View |
Ownership |
2024-10-07 4:58 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Strategy |
0 | $0 | 378,040 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-12 08:40 am |
N/A 2034-08-12 |
LEXICON PHARMACEUTICALS INC. | LXRX | Corrigan Brian SVP, Regulatory & QA |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2024-07-29 5:31 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Siren L.L.C. Invus Global Management LLC Director 10% Owner |
0 | $0 | 38,918,903 (Indirect) |
View |
| 2024-07-08 Option Award |
2024-07-08 5:27 pm |
N/A 2034-07-08 |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and COO |
307,000 | $0 | 307,000 (Direct) |
View |